The company’s paid-in share capital on the balance sheet date was EUR 557,881,540.40. The company has a total of 328,165,612 shares, which are divided into 36,339,550 Series A shares and 291,826,062 Series B shares. Each Series A Share entitles its holder to twenty (20) votes at a General Meeting of Shareholders, and each Series B Share entitles the holder to one (1) vote. All shares carry the same right to receive a dividend. The company is not aware of any agreements between shareholders relating to the ownership of shares in the company.
| Changes in share capital 2000-2009 |
|
|
|
Number of shares |
Share capital, EUR million |
| 1999 |
Share capital. 31 Dec 1999 |
138,999,425 |
233.8 |
| 2000 |
Change in nominal value
5 May 2000, from share premium funds
|
|
2.5 |
| 2001 |
Rights issue
Rights issue
Share capital, 31 Dec 2001 |
35,000,000
5,000,000
178,999,425 |
59.5
8.5
304.3 |
| 2002 |
No changes |
|
|
| 2003 |
No changes
Share capital, 31 Dec 2003 |
178,999,425 |
304.3 |
| 2004 |
Rights issue (EUR 3 per share)
Rights issue (EUR 3 per share)
Share capital, 31 Dec 2004 |
148,633,415
532,772
328,165,612 |
252.7
0.9
557.9 |
| 2005-2009 |
No changes
Share capital, 31 Dec 2009 |
328,165,612 |
557.9 |